407 related articles for article (PubMed ID: 23894559)
21. In vitro inhibition of calcium oxalate crystallization and crystal adherence to renal tubular epithelial cells by Terminalia arjuna.
Mittal A; Tandon S; Singla SK; Tandon C
Urolithiasis; 2016 Apr; 44(2):117-25. PubMed ID: 26424092
[TBL] [Abstract][Full Text] [Related]
22. Purification and characterization of an anticalcifying protein from the seeds of Trachyspermum ammi (L.).
Kaur T; Bijarnia RK; Singla SK; Tandon C
Protein Pept Lett; 2009; 16(2):173-81. PubMed ID: 19200041
[TBL] [Abstract][Full Text] [Related]
23. Aspidopterys obcordata vine inulin fructan affects urolithiasis by modifying calcium oxalate crystallization.
Sun P; Liao SG; Yang RQ; Lu CL; Ji KL; Cao DH; Hu HB; Lu JM; Song XZ; Wu M; Jia HZ; Xiao CF; Ma ZW; Xu YK
Carbohydr Polym; 2022 Oct; 294():119777. PubMed ID: 35868792
[TBL] [Abstract][Full Text] [Related]
24. The hole truth: intracrystalline proteins and calcium oxalate kidney stones.
Ryall RL; Fleming DE; Grover PK; Chauvet M; Dean CJ; Marshall VR
Mol Urol; 2000; 4(4):391-402. PubMed ID: 11156707
[TBL] [Abstract][Full Text] [Related]
25. Role of biomolecules from human renal stone matrix on COM crystal growth.
Aggarwal S; Tandon CD; Forouzandeh M; Singla SK; Kiran R; Jethi RK
Mol Cell Biochem; 2000 Jul; 210(1-2):109-19. PubMed ID: 10976764
[TBL] [Abstract][Full Text] [Related]
26. Characterizations of PMCA2-interacting complex and its role as a calcium oxalate crystal-binding protein.
Vinaiphat A; Thongboonkerd V
Cell Mol Life Sci; 2018 Apr; 75(8):1461-1482. PubMed ID: 29085954
[TBL] [Abstract][Full Text] [Related]
27. Effects of high-dose uric acid on cellular proteome, intracellular ATP, tissue repairing capability and calcium oxalate crystal-binding capability of renal tubular cells: Implications to hyperuricosuria-induced kidney stone disease.
Sutthimethakorn S; Thongboonkerd V
Chem Biol Interact; 2020 Nov; 331():109270. PubMed ID: 32991862
[TBL] [Abstract][Full Text] [Related]
28. Physical chemical studies of calcium oxalate crystallization.
Nancollas GH; Smesko SA; Campbell AA; Richardson CF; Johnsson M; Iadiccico RA; Binette JP; Binette M
Am J Kidney Dis; 1991 Apr; 17(4):392-5. PubMed ID: 2008905
[TBL] [Abstract][Full Text] [Related]
29. Proteome of human calcium kidney stones.
Canales BK; Anderson L; Higgins L; Ensrud-Bowlin K; Roberts KP; Wu B; Kim IW; Monga M
Urology; 2010 Oct; 76(4):1017.e13-20. PubMed ID: 20709378
[TBL] [Abstract][Full Text] [Related]
30. [Uronic-acid-rich protein: a new glycoprotein inhibiting the crystallization of calcium oxalate in vitro].
Atmani F; Lacour B; Daudon M
Nephrologie; 1996; 17(3):157-62. PubMed ID: 9064564
[TBL] [Abstract][Full Text] [Related]
31. Assessment of crystallization risk formulas in pediatric calcium stone-formers.
Sikora P; Zajaczkowska M; Hoppe B
Pediatr Nephrol; 2009 Oct; 24(10):1997-2003. PubMed ID: 19333626
[TBL] [Abstract][Full Text] [Related]
32. Potential role of fluctuations in the composition of renal tubular fluid through the nephron in the initiation of Randall's plugs and calcium oxalate crystalluria in a computer model of renal function.
Robertson WG
Urolithiasis; 2015 Jan; 43 Suppl 1():93-107. PubMed ID: 25407799
[TBL] [Abstract][Full Text] [Related]
33. Effects of an aqueous extract from Phyllantus niruri on calcium oxalate crystallization in vitro.
Barros ME; Schor N; Boim MA
Urol Res; 2003 Feb; 30(6):374-9. PubMed ID: 12599017
[TBL] [Abstract][Full Text] [Related]
34. A novel antilithiatic protein from Tribulus terrestris having cytoprotective potency.
Aggarwal A; Tandon S; Singla SK; Tandon C
Protein Pept Lett; 2012 Aug; 19(8):812-9. PubMed ID: 22702898
[TBL] [Abstract][Full Text] [Related]
35. Development of a two-stage model system to investigate the mineralization mechanisms involved in idiopathic stone formation: stage 2 in vivo studies of stone growth on biomimetic Randall's plaque.
O'Kell AL; Lovett AC; Canales BK; Gower LB; Khan SR
Urolithiasis; 2019 Aug; 47(4):335-346. PubMed ID: 30218116
[TBL] [Abstract][Full Text] [Related]
36. In vitro effects on calcium oxalate crystallization kinetics and crystal morphology of an aqueous extract from Ceterach officinarum: Analysis of a potential antilithiatic mechanism.
De Bellis R; Piacentini MP; Meli MA; Mattioli M; Menotta M; Mari M; Valentini L; Palomba L; Desideri D; Chiarantini L
PLoS One; 2019; 14(6):e0218734. PubMed ID: 31238335
[TBL] [Abstract][Full Text] [Related]
37. Kidney stone matrix proteins ameliorate calcium oxalate monohydrate induced apoptotic injury to renal epithelial cells.
Narula S; Tandon S; Singh SK; Tandon C
Life Sci; 2016 Nov; 164():23-30. PubMed ID: 27593572
[TBL] [Abstract][Full Text] [Related]
38. Dual modulatory effects of diosmin on calcium oxalate kidney stone formation processes: Crystallization, growth, aggregation, crystal-cell adhesion, internalization into renal tubular cells, and invasion through extracellular matrix.
Khamchun S; Yoodee S; Thongboonkerd V
Biomed Pharmacother; 2021 Sep; 141():111903. PubMed ID: 34328112
[TBL] [Abstract][Full Text] [Related]
39. Urine osmolality predicts calcium-oxalate crystallization risk in patients with recurrent urolithiasis.
Kavouras SA; Suh HG; Vallet M; Daudon M; Mauromoustakos A; Vecchio M; Tack I
Urolithiasis; 2021 Oct; 49(5):399-405. PubMed ID: 33635363
[TBL] [Abstract][Full Text] [Related]
40. Protective Cellular Mechanism of Estrogen Against Kidney Stone Formation: A Proteomics Approach and Functional Validation.
Peerapen P; Thongboonkerd V
Proteomics; 2019 Oct; 19(19):e1900095. PubMed ID: 31475403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
